News

Thyroid tumor reclassification eases burden, raises diagnostic questions


 

FROM JAMA ONCOLOGY

References

Dr. Nikiforov is a consultant for Quest Diagnostics. A coauthor, Dr. Sylvia Asa, is a member of the medical advisory board of Leica Aperio, and another coauthor, Dr. Virginia LiVolsi, is a consultant for Veracyte Inc. The project used a facility supported by the National Cancer Institute, and molecular analysis was supported in part by funds from the University of Pittsburgh Cancer Institute and the University of Pittsburgh Medical Center. The Endocrine Pathology Society working group conference was supported by a grant from CBLPath Inc. Dr. Angelos and Dr. Zeiger reported having no disclosures.

sworcester@frontlinemedcom.com

Pages

Recommended Reading

Moderate THST was most effective at treating thyroid cancer
MDedge Surgery
New Cushing’s guidelines emphasize team approach
MDedge Surgery
Core needle biopsy proves sensitive for first-line thyroid nodule diagnosis
MDedge Surgery
VIDEO: More routine use of unilateral thyroidectomy advocated for papillary thyroid microcarcinoma
MDedge Surgery
VIDEO: Proposed revision of medullary thyroid cancer staging improves risk-stratification analysis
MDedge Surgery
Negative sestamibi scan for primary hyperparathyroidism can mean no referral or surgery
MDedge Surgery
Post-parathyroidectomy follow-up may need to be open-ended
MDedge Surgery
Surgery has edge over surveillance for micropapillary thyroid cancer
MDedge Surgery
Surgery for PHPT improves sleep quality
MDedge Surgery
Parathyroidectomy before kidney transplant may reduce complications
MDedge Surgery